Close Menu
    What's Hot

    Longevity & Mortality Investor Conference 2026

    May 19, 2026

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026

    International Life Settlement Forum 2026

    May 18, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      Longevity & Mortality Investor Conference 2026

      May 19, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      International Life Settlement Forum 2026

      May 18, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    7,000 Steps Each Day Keeps the Doctor Away. But What Is the Impact on Insurers and Pensions?

    Mortality September 10, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The claim that walking 10,000 steps each day makes a significant difference to one’s health didn’t actually come from medical research — the general consensus is that it started as a marketing campaign in Japan in the 1960s. 

    In 1965, after the Tokyo Olympics, there was a big fitness boom in Japan. Yamasa Clock and Instrument Company created one of the first pedometers and branded it the “Manpo-kei”, which means “10,000 steps meter” in Japanese. The number 10,000 may have been chosen partly because it’s a nice round, memorable number but at the time, there wasn’t strong scientific evidence that 10,000 was a magic threshold. It was more of a catchy slogan to promote walking and health awareness. 

    It turns out that the magic number is actually 7,000. That is according to Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis, an article published in The Lancet Public Health in August. 

    The authors analysed data from over 160,000 adults and found that walking approximately 7,000 steps per day is associated with reductions in the risk of several serious health outcomes, including all-cause mortality (47% reduction), cardiovascular disease (25% reduction), cancer (6% reduction), type 2 diabetes (14% reduction), dementia (38% reduction), depression (22% reduction), and falls (28% reduction). 

    Current mortality tables do not factor in the number of steps walked each day by an individual – after all, the ability to collect this data is only fairly new, with the advent of smartphones and associated GPS tracking technology.  

    But if everyone in an insurance cohort – a defined benefit pension cohort from a pension risk transfer deal, a book of life annuity business, or even a standard whole of life insurance cohort – walked 7,000 steps a day, the mortality table would, most likely, look very different than it does now. 

    But how can pensions and insurers actually collect and use this data? And what is the reality for insurers and pensions that want to collect data – on enough people? 

    “Activity level data, including steps, can be gathered from a number of sources, including smartphones, wearable watches, patches, health related apps, etc. This data is able to be captured on any individual that grants access to their data,” said Mary Bahna-Nolan, Senior Director, Insurance Consulting & Technology at WTW.  

    “For insurance applications where there is an application process, an insurer can request access to such information which often includes both current and historical data but for a pension scheme or business that covers a group cohort, it becomes more challenging to obtain the data on a sufficient number of individuals – at least, today.” 

    There are people – likely plenty of them – that do monitor their daily number of steps; smartphones now come with built-in apps which provide this information at no charge. As with any new or emerging technology, there are teething issues, but patterns will emerge eventually. 

    “Different devices and how an individual uses them, wears them, etc. can provide different measurable data. Over the course of time, however, consistency in patterns of activity will likely be the similar to use in certain scoring models and measures. In addition, the technology for capturing and monitoring activity and inactivity levels continues to improve and thus, so should the reliability of the data itself. In addition, the models, as they obtain more data points, will become better calibrated to a particular population,” said Bahna-Nolan. 

    Whether or when insurance and pension cohorts get to a place where most of their cohorts are doing their 7,000 steps is up for debate; after all, an article from The Lancet Global Health just a year ago, based on physical activity reported by adults (aged ≥18 years) in population-based surveys, suggests that insufficient physical activity increased in people aged 60 years and older in all regions and both sexes. 

    So, is there realistically anything for pensions and insurers to be worried about in terms of their mortality models underestimating the extent to which people are walking 7,000 steps per day – and therefore, their mortality profile? 

    “Behavioural change is slow and often linked to educational background. Insurers already use a wide range of proxy variables such as income, education and postal code, to gauge likely good or bad health behaviours and willingness to change. As such the study will not cause immediate concern for those pricing individual annuities or group annuity policies,” said Steven Baxter, Chief Data Scientist at Club Vita. 

    “That said, we are aware of several insurers who are actively assessing the practicalities of using step count data to improve their approach to understanding the mortality or longevity risk of policyholders and form part of underwriting. These organisations will no doubt be reading this study with interest.” 

    Indeed, a recent study by WTW found that wearable-driven mortality modelling does improve underwriting accuracy and while there are many challenges for pensions or insurers to get accurate step count data – and enough of it – for inclusion in a model, you have to start somewhere. 

    “For any insurance use, it is important that insurers and pensions perform feasibility studies to understand the data and how to best calibrate it to their target population; indeed, we only recommend incorporating such data into key decision making after careful study and analysis of the implications on specific use cases,” said Bahna-Nolan. 

    “But this is an area that will continue to emerge over time, but we can’t understand the implications and opportunities if we don’t start collecting the information and measuring the outcomes.” 

    2025 - September Clinical Mortality Mortality Risk Volume 4 Issue 9 – September 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026By LMI Newsdesk

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble

    Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

    April 22, 2026By Greg Winterton

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026By Mark McCord
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.